Evaluation of Efficacy and Safety of AGP on Immune Enhancement

Chonbuk National University

Status: Completed

Conditions: Immune Function

Treatments: Dietary Supplement: AGP; Dietary Supplement: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT03330392

CTCF2_2017_AGP

Details and patient eligibility

About

The researchers investigated the immune enhancing effects of AGP for Korean participants.

Full description

The aim of the study is to investigate the effects of AGP on immune enhancement based on 8 week, randomized, double-blind, placebo-controlled clinical trial.

Enrollment: 80 patients

Sex: All

Ages: 20 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• The levels of white blood cells within range 3x10^3/μL~8x10^3/μL
• have had at least two cold in the last 12 months.

Exclusion criteria

• subjects with BMI<18.5 kg/m^2
• subjects taking medications such as immune related drug or functional foods
• history of disease that could interfere with the test products or impede their absorption
• pregnant or lactating women and heavy smokers.
• being judged by the responsible physician of the local study center as unfit to participate in the study

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

80 participants in 2 patient groups, including a placebo group

AGP

Experimental group

Description:

take two tablets per day (500 mg/day) for 8 weeks.

Treatment:

Dietary Supplement: AGP

Placebo

Placebo Comparator group

Description:

take two tablets per day for 8 weeks.

Treatment:

Dietary Supplement: Placebo